6533b7dafe1ef96bd126ee70
RESEARCH PRODUCT
How the Pricing Strategy of 2nd Generation HCV Direct Antiviral Agents Can Affect the Number of Treated Patients in Italy and the National Drug Budget
D. LidonniciE.p. LanatiCalogero Cammàsubject
Health PolicyDrug budgetPublic Health Environmental and Occupational HealthAdvertisingBusinessAffect (psychology)year | journal | country | edition | language |
---|---|---|---|---|
2013-11-01 | Value in Health |